Saliwanchik, Lloyd & Eisenschenk
Tricyclic lactones for treatment of cancer
The present invention discloses novel compounds useful for the inhibition of IL-6/STAT signaling and/or PI3K/NF-κB signaling in the treatment of associated diseases or conditions, e.g. cancer. A pharmaceutical composition comprising such novel compounds, its use and a method thereof, is also disclosed.
Glactone Pharma Development AB
A A A A A A A A A C A C C A A A A A A A A A A A A A A
A61K A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P C07D C07D A61P A61K A61P A61P A61K A61P A61P A61P A61P A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Ritha Eduardo Martin Olov
Gidlöf Muñoz Johansson Sterner